NDC 83021-0617-05: Anubis Barcelona Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin .0000001 g/5mL; .0125 g/5mL; .0025 g/5mL; 5 .00001 g/5mL; .0069 g/5mL; .000035 g/5mL; .00500065 g/5mL; .01 g/5mL; 3.12515585 mL/5mL Concentrate, 5 mL Vial
This is a package of 5 mL of Anubis Barcelona Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin .0000001 g/5mL; .0125 g/5mL; .0025 g/5mL; 5 .00001 g/5mL; .0069 g/5mL; .000035 g/5mL; .00500065 g/5mL; .01 g/5mL; 3.12515585 mL/5mL Concentrate from ANUBIS COSMETICS SL, first listed with the FDA Oct 2022 and currently FDA-listed, this package's marketing is listed to end Sep 2027. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 83021-617-05 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 83021 labeler · 617 product · 05 package
- Package marketed since
- Oct 21, 2022
- Package marketing ended
- Sep 20, 2027
- Sample package
- No — commercial package
- Barcode (UPC)
- 8436019940617
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Anubis Barcelona is a topical concentrate marketed as an OTC monograph product. It contains allantoin, niacinamide, and levomenol, ingredients typically used in skin care products to help soothe, moisturize, and condition the skin. The product also includes preservatives (parabens), fragrance components, and a colorant (FD&C Yellow No. 5). This concentrate is designed to be diluted before use on skin.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 83021-0617-05 You're viewing this Main listing | 5 mL in 1 VIAL, GLASS | 2022-10-21 | Sep 20, 2027 | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Anubis Barcelona .0000001 g/5mL; .0125 g/5mL; .0025 g/5mL; 5 .00001 g/5mL; .0069 g/5mL; .000035 g/5mL; .00500065 g/5mL; .01 g/5mL; 3.12515585 mL/5mLthis 83021-0617-05 | ANUBIS | 5 ml | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
0.0025 g / 5 mL
UNII 9E8X80D2L0
A synthetic form of vitamin E used as an antioxidant and preservative in medications. It helps prevent the active ingredients from degrading when exposed to oxygen or light.
-
0.005 g / 5 mL
UNII 8NLQ36F6MM
Edetate disodium anhydrous is a chemical compound that binds to metal ions in a medicine. It's used as a stabilizer to prevent unwanted chemical reactions and help keep the drug product effective during storage.
-
0.00005 g / 5 mL
UNII 68Y4CF58BV
Pyridoxine hydrochloride is a form of vitamin B6, added to medicines as a nutritional supplement or to meet dietary requirements. It supports the body's metabolism and nerve function.
-
0.0015 g / 5 mL
UNII 4550K0SC9B
Sodium acetate is a salt derived from acetic acid. It acts as a buffer to help maintain the medicine's pH stability and may serve as a preservative or solubilizer in liquid formulations.
-
0.0003 g / 5 mL
UNII M572600E5P
Thiamine hydrochloride is a form of vitamin B1, a water-soluble nutrient. It's added to some medicines as a nutritional supplement or active ingredient component, though when listed as an excipient it typically serves as a stabilizer or minor additive in the formulation.
-
0.000049 g / 5 mL
UNII 1D1K0N0VVC
A fat-soluble form of vitamin A used as a colorant and nutritional fortification ingredient. It gives products a yellow or orange tint and increases vitamin A content in the formula.
6 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from ANUBIS COSMETICS SL labeler code 83021
- AnubisMed Azelaic Acid, Salicylic Acid 7 g/50mL; 400 4.9965 g/50mL; 10 g/50mL; 2.7 g/50mL; 1.62 mL/50mL; 1 g/50mL; 22.68 mL/50mL Liquid NDC 83021-402-50
- Anubis Barcelona Proteoglycan, Glycerin, Butylene Glycol .162 g/20mL; .08 g/20mL; .024 g/20mL; 16.4578 mL/20mL; .46 g/20mL; .4 g/20mL; 20 .2 g/20mL; .0002 g/20mL; 4 .002 g/20mL; 13576 .03 g/2 Concentrate NDC 83021-495-20
- Anubis Barcelona Ferulic Acid, Vitamin C, DMAE .96 mL/20mL; .02 g/20mL; .12 g/20mL; 14.26 mL/20mL; 2 g/20mL; 35 CASTOR OIL .18 g/20mL; 13576 .02 g/20mL; 2 g/20mL; .1 g/20mL Concentrate NDC 83021-501-20
- Anubis Barcelona DMAE .555 g/30mL; .243 g/30mL; .09 g/30mL; 13576 .027 g/30mL; .024 g/30mL; .0012 g/30mL; 1000 MW) .0009 g/30mL; .0003 g/30mL; .0006 g/3 Concentrate NDC 83021-546-30
- AnubisMed SPF 50 Broad Spectrum Protection Fluid Emulsion .025 g/50mL; .005 g/50mL; .00275 g/50mL; .22 g/50mL; 1.8 g/50mL; .0018 g/50mL; 2.5 g/50mL; 27.55 mL/50mL; 135 Cream NDC 83021-551-50
- Anubis Barcelona DMAE, ZIRHAFIRM 5.988 g/60mL; .0006 g/60mL; .0006 g/60mL; 2.496 g/60mL; .456 g/60mL; 1.2 g/60mL; 1.5 g/60mL; .024 g/60mL; .18 g/60mL Cream NDC 83021-553-60
- Anubis Barcelona Regul OIl Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Arctium Majus Root Extract 3.512 mL/10mL; 40 HYDROGENATED CASTOR OIL .04 g/10mL; .0345 g/10mL; .0138 g/10mL; .00007 g/10mL; .025 g/10mL; .0006 g/10mL; .0000002 g/10mL Concentrate NDC 83021-624-10
- Anubis Barcelona Protective Line Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene 3.5982 g/50mL; .425 g/50mL; .1 g/50mL; 1.8 g/50mL; 2.5 g/50mL; 2.5 g/50mL; 2.1 g/50mL; 450000 MW) 27.55 mL/50mL; .575 g/50mL Cream NDC 83021-686-50
- Anubis Barcelona Total Hydrating Betaine, Glycerin, Polysorbate 20 5 g/250mL; 13576 .125 g/250mL; 1 .00025 g/250mL; 1.75 g/250mL; 5 g/250mL; 2.25 g/250mL; .125 g/250mL; 20 2.75 g/250mL; 232.139 mL/250mL; .75 Lotion NDC 83021-692-01
- Anubis Barcelona Regul Oil Propylene Glycol, Panthenol, Thiamine HCL 52.5 mL/250mL; .025 g/250mL; .25 g/250mL; .0225 g/250mL; .0025 g/250mL; 40 HYDROGENATED CASTOR OIL 2 g/250mL; .5 g/250mL; .14375 g/250mL Lotion NDC 83021-740-01
- Anubis Barcelona Regul Oil Cetearyl Ethylhexanoate, Propylene Glycol, Glyceryl Stearate Se .08784 g/200mL; .003398 g/200mL; .002132 g/200mL; 3.5436 mL/200mL; 1.6 g/200mL; 1.3 g/200mL; .1 g/200mL; .4 g/200mL; 155.839258 mL/200mL Cream NDC 83021-742-01
- ANUBISMED HA HYALURONIC .05 g/50mL; 2.5 g/50mL; 13576 .225 g/50mL; .875 g/50mL; .3 g/50mL; .0535 g/50mL; 1.996 g/50mL; .0038 g/50mL; .004 g/50mL Cream NDC 83021-750-50
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
RO Concentrate indications
⏱️ Dosage and Administration ▾
RO Concentrate dosage
⚠️ Warnings ▾
RO Concentrate warnings
🧪 Active Ingredient ▾
RO Concentrate ingredients
🧪 Inactive Ingredients ▾
RO Concentrate ingredients list
🎯 Purpose ▾
RO Concentrate purpose
📄 Do Not Use ▾
RO Concentrate do not use
📄 Keep Out of Reach of Children ▾
RO Concentrate keep
📄 Package Label / Principal Display Panel ▾
RO Concentrate display
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |